Objective: It is known that oxidative stress could be an important factor in the pathogenesis of vitiligo disease. We aimed to investigate the possible relationship between vitiligo pathogenesis and the change of antioxidant capacity of skin and plasma in patients with vitiligo.
INTRODUCTION
The etiology and pathogenic mechanism of vitiligo is still unclear. Recently, the involvement of oxidative stress in the pathophysiology of vitiligo has been shown. [1, 2] Increased oxidative stress, accumulation of free radicals and reactive oxygen species (ROS) and associated changes in epidermal component of vitiliginous skin have been reported many times. [3] [4] [5] However, ROS are generated as by-products of normal cellular metabolism; an unbalanced production of ROS occurs frequently in cells, particularly following exposure to various chemicals, radiation, hyperoxia, and ischemiareperfusion or during tissue inflammation. Moreover, it has recently been revealed that ROS modulate the physiological state of cells and influence cell death. [6] A relationship between ROS and apoptosis has been suggested by many studies. Some histological and laboratory data indicate that apoptosis plays an important role during degeneration of melanocytes in vitiligo patients. [7, 8] Mammalian cells are equipped with both enzymatic and nonenzymatic antioxidant activities to minimize the cellular oxidative damage. The enzymatic antioxidant mechanisms include superoxide dismutases (SOD), catalase (CAT) and glutathione peroxidase (GPx), and these antioxidants can prevent oxidative damage in several cell types. In vitiligo, both an imbalance of the intracellular redox status and a significant depletion of enzymatic and non-enzymatic antioxidants feature of vitiligo patients, and an abnormal oxidative stress might be the causes of melanocyte degeneration. [2] We aimed to investigate the antioxidant enzyme activity levels of plasma and skin in vitiligo patients and in healthy controls. We used normal full thickness skin samples for this study. So far, there is no study about antioxidant enzymes on full thickness skin biopsy in patients with vitiligo.
MATERIALS AND METHODS
Forty (23 female, 17 male) inactive vitiligo patients and fifteen (11 female, 4 male) healthy controls were included in this study. Patient ages ranged from 9 to 56 years (27±13). The control group consisted of healthy volunteers, whose ages ranged from 16-52 years (35±13). The Ethic Committee approved the protocol for this study; all subjects gave his/her protector informed consent. The following laboratory tests were performed; erythrocyte sedimentation rate, blood cell counts and indexes; glucose, electrolytes, kidney and liver function tests. The patients with normal biochemical analysis results were included the study. The patients had not been under any therapeutic regimen for the previous 2 months and had not received drugs containing iron and/or vitamins. All individuals with any history of smoking and alcohol habits were excluded from the study.
Preparation of the samples:
Skin and blood samples were taken at the same time. Skin samples of controls and vitiligo patients, from non-lesional and lesional skin, were taken by 4 mm punch biopsy (two times) under local anesthesia with prilocain (Citanest® %2), and immediately after the biopsy, subcutaneous lipid tissue were separated gently. Tissues were frozen in liquid nitrogen, and stored in a deep freeze (-40 C) for at most 2 weeks until they were used. Just before measurement, all the frozen tissues were transferred into 14 ml tubes. PBS (1 ml) placed in a round bottom tube and homogenized using a homogenizer (Ultra Turpax T2S Basic-Labortechnik) at 20 000-cycle speed until tissue was fully ground (about 30-60 seconds). Then samples were centrifuged at 15000 g. for 15 minutes.
Ten ml blood was drawn from the median cubital vein of the patient and control groups into heparin washed tubes. The blood samples were centrifuged at 1000x g for 10 minutes at +4 0 C, and the upper plasma phase was withdrawn by pipette and transferred into polypropylene tubes, and stored at -40 0 C.
Determination of Protein Levels:
Protein determinations in plasma and tissue homogenates were made according to Lowry et al. using BSA as standard. [9] Measurement of CAT Activity: CAT activity was measured by the Aebi [10] , from xanthine by xanthine oxidase and reduction of nitroblue tetrazolium (NBT) by the produced O 2 -. SOD enzyme also dismutated two superoxide and produced H 2 O 2 . [11] Measurement of GPx Activity: GPx activity measurements were conducted according to Lawrence and Burk [12] . The change in absorbance at 340 nm was monitored for 1 min. A blank with all ingredients except supernatant was also monitored. Specific activity was calculated as U/mg protein for plasma and supernatant samples.
Statistical analyses were carried out on the SPSS 10 computer program, utilizing "Mann-Whitney U test", "Wilcoxon Signed Rank Test" and "partial correlation coefficients" tests.
RESULTS
All results were shown in Tables 1 and 2 .
Plasma antioxidant enzyme activities were found statistically insignificant in the vitiligo patients compared to the control group (p>0.05). However, the results showed that GPx activities were increased significantly in vitiligo patients' uninvolved (mean±SD:182.13+13.48 U/mg protein) (p=0.004) and vitiliginous skin (mean±SD:170.98+12.35 U/mg protein) (p=0.005) compared with control subjects. The CAT activities were found to be high (mean±SD:94.99+10.47 U/mg protein) in the uninvolved skin of vitiligo patients, but not in vitiliginous skin (mean+SD: 78.92+10.34 U/mg protein) when compared with control group skin (p=0.014). There was no significant difference in SOD activities in both skin examples, ie vitiliginous (mean±SD:0.64+0.09 U/mg protein), (p>0.05) and uninvolved sites (mean±SD:0.89+0.15 U/mg protein), (p>0.05). Although skin and plasma SOD and CAT levels were not correlated, there was a significant correlation between skin and plasma GPx levels (p=0.036).
DISCUSSION
Our results clearly show that the serum composition of antioxidant enzymes in patients with vitiligo are not significantly different from those of healthy controls. The skin is the largest tissue of the human body, with an approximate size of 1.8 m 2 ,where numerous fine-tuned mechanisms act in a concerted manner to maintain homeostasis. Recently, it has been shown in vivo and in vitro that patients with the pigmentation disorder vitiligo accumulate mM levels of hydrogen peroxide (H 2 O 2 ) and high concentration of ROS in their epidermis [13] . It is well established that up to millimolar levels of H 2 O 2 lead to the upregulation of antioxidant enzymes such as SOD, CAT and GPx. [14, 15] Possible sources of endogenous H 2 O 2 production increased the activities of epidermal monoamine oxidase A, NADPH-oxidases, SOD, inducible nitric oxide synthase, increased levels of TNF and photo-oxidation of epidermal 6-biopterin and sepiapterin. [16] Increased H 2 O 2 concentration may cause the increased antioxidant capacity to compensate the oxidative damage of subcellular components such as lipids, proteins and DNA.
On the other hand, Schallreuter et al. [17, 18] reported that a defective recycling of tetrahydrobiopterin in the phenylalanine hydroxylase reaction in the epidermis has been also proposed as a possible pathogenetic factor of vitiligo. This metabolic impairment might lead to an accumulation of H 2 O 2 within the epidermis and to the consequent oxidation of (6R)-5,6,7,8-tetrahydrobiopterin, the essential cofactor of phenylalanine hydroxylation reaction, to 6-biopterin, which is toxic to human melanocytes. [19] Davis et al. [20, 21] established previously that the inhibition of phenylalanine hydroxylase causes the release of H 2 O 2 due to the instability of the 4a-peroxytetrahydrobiopterin intermediate in the catalytic cycle. It is possible that the inhibition of phenyl alanine hydroxylase via H 2 O 2 yields a decreased L-tyrosine pool with an altered melanin biosynthesis in vitiligo melanocytes.
The generation of H 2 O 2 as a by-product could be responsible for the alteration of CAT and GPx enzyme activities in the skin and melanocyte damage. Jones et al. [22] reported that GPx has a higher affinity for H 2 O 2 than CAT, suggesting that the peroxides are metabolized mainly by GPx in the organism. In general, the most striking changes between the enzymes are seen in GPx. The probable reason for this is that the first defence against the peroxides comes from the GPx and increasing oxidative stress and CAT are involved in this defence. Therefore, probably GPx enzyme activity may be more sensitive to high H 2 O 2 concentration, as according to our skin results. It seems possible that CAT and GPx activities in uninvolved skin might be increased by upregulation mechanisms, as an adaptation against to oxidative stress. Agrawal et al. [5] reported increased MDA levels and SOD activity in all different age groups of vitiligo patients and decreased whole blood reduced glutathione levels and erythrocyte GPx and glucose-6-phosphate dehydrogenase activity. Arican et al. [23] reported increased MDA levels and SOD activity also. However, Passi et al. [16] measured SOD levels in the epidermis of patients with active vitiligo and reported that there was no significant change compared with control. In addition, Picardo et al. [24] reported that in-patients with active vitiligo, the levels of blood Cu/ Zn SOD activities were not different from controls. Similarly, in our previous study, we reported increased erythrocyte SOD activity and unchanged plasma GPx and SOD activity levels in vitiligo patients compared with healthy controls. [25] Also,Y ld r m et al. [26] reported significantly higher level of erythrocyte and plasma SOD activity among patients with generalized stable vitiligo. We could not find any change of the enzyme activities in plasma. Oxidative stress and antioxidant enzyme activities are active and repeatedly change. We believe that these different results depend on activity and/or the stage of the vitiligo disease, or might depend on seasonal and/or daytime fluctuations of skin and plasma antioxidant status at the time of biopsy and blood sampling. On the other hand, the variations of antioxidant enzyme activities in oxidative stress are linked with genetic control mechanisms. It is possible that, in the case of low concentrations of ROS, mRNA expression of some antioxidant enzymes may be stimulated. [27, 28] However, it has not yet been determined extensively which molecules actively participate in this mechanism. Specific molecular studies on the subject are still needed.
In conclusion, we believe that the support of the skin antioxidant system via nonenzymatic antioxidant compounds and antioxidant enzymes may be useful in preventing melanocyte degeneration which occurs due to oxidative damage in vitiligo.
